Epilepsy News

Researchers observed differences in survival between antiseizure medications in post-stroke epilepsy, with lamotrigine and levetiracetam appearing to be reasonable first-line treatment options, according to a study in JAMA Neurology.

A validated score was able to predict among which patients with epilepsy stereoelectroencephalography was unlikely to identify a focal seizure-onset zone, according to results of a cohort study published in JAMA Neurology.

Specialty epilepsy care availability increased in the U.S. following implementation of the National Association of Epilepsy Centers’ accreditation program, according to study results published in Neurology.

Study results published in JAMA Neurology show higher odds of seizures during rewarming correlate with death or disability at 2 years in infants at risk, demonstrating the need for EEG monitoring during rewarming.

Patients with isocitrate dehydrogenase wild-type glioblastoma who used levetiracetam for the duration of chemoradiation may have a higher overall survival rate, according to an observational, retrospective cohort study in Neurology.

Healio’s most-viewed neurology stories in October highlight cognitive impairment after COVID-19 infection, vaccine risks and advances in Alzheimer’s therapies, including the FDA granting breakthrough therapy designation for gantenerumab.

Prescriptions for Z-hypnotics, selective serotonin reuptake inhibitors, serotonin and norepinephrine reuptake inhibitors, and benzodiazepines have increased during the COVID-19 pandemic.

Long-term adjunctive perampanel treatment was efficacious and generally well tolerated among older patients with focal-onset seizures, according to findings presented at the annual meeting of the American Neurological Association.

The American Academy of Neurology released a position statement that highlights the significant challenges high drug prices create for patients, physicians, health systems and payers.

The American Society for Stereotactic and Functional Neurosurgery released a position statement supporting the use of magnetic resonance-guided laser interstitial thermal therapy for patients with drug-resistant epilepsy.